This suggested that RAD51-mediated treatment resistance in oral cancer occurs through mechanisms other than stem cell signaling and the role of RAD51 in the resistance to chemotherapy and radiotherapy requires further exploration, for example whole genome sequencing in the future. Here, RAD51 is linked to lip and oral cavity carcinoma.